B. Riley issued their Q1 2025 earnings estimates for Customers Bancorp in a research note issued to investors on Monday, ...

Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

B. Riley analyst Kyle Bauser raised the firm’s price target on ClearPoint Neuro (CLPT) to $20 from $15 and keeps a Buy rating ...

Analysts at B. Riley reduced their FY2024 earnings estimates for shares of Ladder Capital in a research report issued to clients and investors on Monday, January 27th. B. Riley analyst R. Binner now ...

The recent decline in Foghorn Therapeutics' stock was attributed to the discontinuation of another of its products, FHD-286. However, the analysts emphasized that this event does not impact their ...

President Donald Trump plans to sign the Laken Riley Act into law as his administration's first piece of legislation.

Redwire Corp (NYSE:RDW) was upgraded to Buy from Neutral at financial services company B. Riley, which also hiked its price target on the space infrastructure provider to $27.00 from $9.50.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 2.13% of ...

Ahead of Trump's signing, Laken Riley's mother, Allyson Phillips, spoke to those in the room. Phillips began by thanking ...